Living Cell Technologies Limited
Living Cell Technologies Limited
Your view on LVCLY
Overview
What the company does, where it operates, and who runs it.
About Living Cell Technologies Limited
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- David Richard Hainsworth
- Headquarters
- Tower 2, Sydney, NSW, AU
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- David Richard Hainsworth
- Headquarters
- Tower 2, Sydney, NSW, AU
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.